Status:
UNKNOWN
Medical Thoracoscopy in Treatment Outcomes of Empyema Management
Lead Sponsor:
Hend Mohamed Sayed Mohamed
Conditions:
Empyema
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
To evaluate the efficacy of drainage achieved by thoracoscopy vs tube drainage alone. To compare clinical outcomes such as length of hospital stay, need for additional procedures, and treatment failu...
Detailed Description
Empyema is a serious infection characterized by pus accumulation in the pleural space. Effective drainage and treatment is necessary for resolution. Traditionally, intercostal tube placement was stand...
Eligibility Criteria
Inclusion
- Confirmed diagnosis of empyema via Imaging tests (e.g. chest x-ray/CT scan)
- Age 18 years or older
- Clinical signs/symptoms consistent with Empyema such as fever, chest pain, coughs
- Pleural fluid loculations/septations seen on Imaging requiring drainage
- No previous drainage procedures done for Current empyema
Exclusion
- Age less than 18 years
- Immunocompromised state or other conditions Contraindications to thoracoscopy
- Previous drainage procedure for current Empyema
- Residual pleural fluid not amenable to drain
Key Trial Info
Start Date :
December 24 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 24 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06132997
Start Date
December 24 2023
End Date
March 24 2025
Last Update
November 15 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.